Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis

Diabetes - United States
doi 10.2337/dbi18-0024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Nonalcoholic Steatohepatitis and Insulin Resistance : Interface Between Gastroenterologists and Endocrinologists

Acta Clinica Belgica
Medicine
2003English

Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Hepatology
MedicineHepatology
2014English

Abdominal Subcutaneous Fat Thickness and Homeostasis Model Assessment of Insulin Resistance as Simple Predictors of Nonalcoholic Steatohepatitis

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

Nonalcoholic Steatohepatitis

English

Association Between Diabetes, Family History of Diabetes, and Risk of Nonalcoholic Steatohepatitis and Fibrosis

Hepatology
MedicineHepatology
2012English

Pathophysiology of Nonalcoholic Steatohepatitis

Juntendo Medical Journal
2017English

Gut Microbiota and Nonalcoholic Steatohepatitis

Folia Pharmacologica Japonica
Pharmacology
2018English

Bile Acid Alterations in Nonalcoholic Fatty Liver Disease, Obesity, Insulin Resistance and Type 2 Diabetes

Current Opinion in Lipidology
NutritionGeneticsCell BiologyMolecular BiologyCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy